| Financial Year |
September 30 2020 |
| Monetary Funds |
79,182,329.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
34,287,223.27 |
| Other Receivables |
28,065,101.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,850,249.68 |
| Dividend Receivable |
-- |
| Inventories |
27,739,761.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,370,548.32 |
| Total Current Assets |
175,644,963.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
27,671,146.35 |
| Fixed Assetes |
18,530,448.06 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
50,317,026.71 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,114,102.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
5,386,398.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
132,019,122.30 |
| Total Assets |
307,664,085.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
240,260.80 |
| Employee Compensation Payable |
2,225,861.62 |
| Taxes Payable |
339,206.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,712,922.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
97,833.79 |
| Other Current Liabilities |
283.66 |
| Sub-Total of Current Liabilities |
12,068,477.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,973,877.55 |
| Total Liabilities |
23,042,354.92 |
| Paid-In Capital(Or Share Stock) |
147,706,873.00 |
| Capital Surplus |
223,982,201.21 |
| Surplus Reserve |
34,192,504.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-121,259,848.45 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
284,621,730.62 |
| Owner's Equity（Stockholder's Equity） |
284,621,730.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
307,664,085.54 |
